Login
← Go Back
Nectar Lifesciences
NECLIFE · Pharma > Pharmaceuticals & Drugs · Chairman: Sanjiv Goyal · MD: Sanjiv Goyal · Listing date: July 19, 2005 · Employees: 1693 · Chandigarh · http://www.neclife.com
Stock Price vs Company Growth
1d
1.8%
1w
4.8%
1m
11.1%
3m
18.7%
6m
26.8%
1y
38.4%
5y
22.7%
10y
11.9%
all
2.1%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 10.2 1.8%
10
14.9
Company Overview
Sales
288 Cr
Growth: -12.5%
Profit after Tax
-328 Cr
Growth: -15.9%
Micro Cap
199 Cr
P/S: 0.7x
Industry P/S: 2.7x
Fundamentals
Sales (Cr) ₹ 288
Growth -12.5%
EBITDA N/A
P/S 0.7x
Dividend 0.0%
P/E N/A
Book Value ₹ 1
PEG Ratio N/A
ROE -1511.8%
P/B N/A
Shareholding Pattern
Institutions
Nsr Direct Pe Mauritius Llc
14.59 %
Ingain Traders, Llc
1.34 %
Iepf
0.02 %
Promoters
Sanjiv Goyal
31.33 %
Sanjiv (Huf)
24.47 %
Others
Increase    Decrease    No change
Company Profile Detailed
Nectar is a global pharmaceutical company specializing in Cephalosporins.
Belongs to (4 Indices)
Investors (30)
share.in...
rajastha...
religare...
Followers (2)
bhaskar6
sanjayda...